Baesed on the above results, we found that chemotherapy activates GSDME-dependent SCLC pyroptosis, releases IL-12, and reshapes the TME, thus promoting the efficacy of PD-L1 inhibitors. This evidence concerns the gene GSDME and small cell lung carcinoma.